top of page
  • White Facebook Icon
  • White Twitter Icon
Search

Divestment

Updated: Jan 12, 2023

Scope law advises an institutional investor in its divestment in connection with Biognosys AG’s strategic partnership with Bruker Corporation.


Biognosys AG and Bruker Corporation (Nasdaq: BRKR) announced a strategic partnership, in which Bruker has made a majority-ownership investment in the ETH spin-off Biognosys. Financial details were not disclosed. Scope law’s client has, together with other investors, sold its shares to Bruker in a secondary transaction, and Bruker will make new primary investments in Biognosys.


 
 
 

Recent Posts

See All
Financing Round

Scope Law AG acts as Swiss legal counsel to PortfoLion Capital Partners in connection with the USD 23 million Series B financing round...

 
 
 
M&A Transaction

Scope Law advises Jung von Matt IMPACT AG , Zurich, on its strategic participation in the Generation Media AG , Zurich. Jung von Matt...

 
 
 
Financing Round

Scope Law advises ETFbook , Zurich, in its EUR 4 million Series A financing round, led by BlackFin Capital Partners BlackFin Capital...

 
 
 

Comments

bottom of page